Resmetirom API
Lewens Labs develops and manufactures Resmetirom API — thyroid hormone receptor-beta (THR-β) agonist, a liver-directed THR-β agonist for metabolic liver disease — used in MASH (NASH) with liver fibrosis, at its GMP facility in Gujarat, India.
Note for Lewens: populate CAS, formula, grade, DMF/CEP & registrations for Resmetirom from the Regulatory master list.
Why Resmetirom rewards process depth.
Resmetirom involves pyridazinone chemistry with demanding purity and scale-up needs.
Lewens' integrated platform — process R&D, analytical development and manufacturing under one team — is built for exactly this kind of technically demanding molecule. We can support Resmetirom as commercial supply, as a second source, or as a development and custom-synthesis programme through our CDMO platform.
Three ways to source Resmetirom.
Ongoing supply
Reliable, on-specification commercial quantities of Resmetirom API for your registered product.
Alternate supplier
De-risk your supply chain for Resmetirom with a dependable additional or backup source.
Custom & CDMO
Process development, improvement or exclusive arrangements for Resmetirom under NDA.
More in Metabolic.
Resmetirom API — FAQs.
Does Lewens manufacture Resmetirom API?
Can Lewens supply Resmetirom as a second source?
What is Resmetirom used for?
Need Resmetirom API?
Request specifications, samples or DMF/CEP documentation — or discuss a second-source or custom-synthesis programme.